Here, we used untargeted metabolomics analysis in conjunction with RNA-seq, to examine the contribution of metabolites and metabolism-related genes in modulating cryptophthalmos susceptibility in Frem2 mutant fetal mice. The gene discussed is FREM2; the disease is cryptophthalmia.